Thomas J. Herzfeld Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-882
| Closed | -$11.9K | – | 155 |
|
|
2023
Q4 | $11.9K | Sell |
882
-116,022
| -99% | -$1.56M | ﹤0.01% | 123 |
|
|
2023
Q3 | $1.46M | Buy |
116,904
+13,414
| +13% | +$167K | 0.56% | 50 |
|
|
2023
Q2 | $1.4M | Buy |
+103,490
| New | +$1.4M | 0.56% | 52 |
|
|
2019
Q2 | – | Sell |
-39,562
| Closed | -$678K | – | 283 |
|
|
2019
Q1 | $678K | Buy |
39,562
+16
| +0% | +$274 | 0.25% | 90 |
|
|
2018
Q4 | $598K | Buy |
39,546
+36,873
| +1,379% | +$558K | 0.24% | 84 |
|
|
2018
Q3 | $55K | Hold |
2,673
| – | – | 0.02% | 160 |
|
|
2018
Q2 | $50K | Buy |
+2,673
| New | +$50K | 0.02% | 178 |
|
|
2017
Q4 | – | Sell |
-69
| Closed | -$1K | – | 324 |
|
|
2017
Q3 | $1K | Buy |
69
+1
| +1% | +$14 | ﹤0.01% | 286 |
|
|
2017
Q2 | $1K | Buy |
68
+1
| +1% | +$15 | ﹤0.01% | 283 |
|
|
2017
Q1 | $1K | Buy |
67
+1
| +2% | +$15 | ﹤0.01% | 294 |
|
|
2016
Q4 | $1K | Buy |
66
+1
| +2% | +$15 | ﹤0.01% | 304 |
|
|
2016
Q3 | $1K | Buy |
65
+2
| +3% | +$31 | ﹤0.01% | 293 |
|
|
2016
Q2 | $1K | Buy |
63
+1
| +2% | +$16 | ﹤0.01% | 306 |
|
|
2016
Q1 | $1K | Buy |
62
+1
| +2% | +$16 | ﹤0.01% | 332 |
|
|
2015
Q4 | $1K | Buy |
61
+1
| +2% | +$16 | ﹤0.01% | 321 |
|
|
2015
Q3 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 322 |
|
|
2015
Q2 | – | Sell |
-58
| Closed | -$2K | – | 312 |
|
|
2015
Q1 | $2K | Sell |
58
-332
| -85% | -$11.4K | ﹤0.01% | 292 |
|
|
2014
Q4 | $10K | Sell |
390
-1,535
| -80% | -$39.4K | 0.01% | 234 |
|
|
2014
Q3 | $43K | Buy |
1,925
+61
| +3% | +$1.36K | 0.02% | 206 |
|
|
2014
Q2 | $39K | Sell |
1,864
-4,736
| -72% | -$99.1K | 0.02% | 211 |
|
|
2014
Q1 | $144K | Buy |
+6,600
| New | +$144K | 0.08% | 161 |
|